Lee's Pharm Competitors and Similar CompaniesClear all
Lee's Pharm's competitors and similar companies include Kadmon, Cosmos Holdings, Sino Biopharmaceutical and Duopharma Biotech.
 Lee's Pharm Lee's Pharm (Lee's Pharmaceutical Holdings) is a company that develops, manufactures, and sells biopharmaceutical products for cardiovascular and infectious diseases areas. |  Kadmon Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C. |  Cosmos Holdings Cosmos Holdings is a fully reporting Pharmaceutical Holding Company based in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe. |  Sino Biopharmaceutical Sino Biopharmaceutical (中国生物制药) is a company engaged in the pharmaceutical manufacturing industry. |  Duopharma Biotech Duopharma Biotech is a pharmaceutical company that specializes in the manufacturing, research, development, and commercialization of generic drugs. | |
Founding Date | Founding Date 1994 | Founding Date 2010 | Founding Date N/A | Founding Date 1997 | Founding Date 1979 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Hong Kong, HK HQ Taipei, TW | Locations New York, US HQ Cambridge, US South Brunswick Township, US Warrendale, US | Locations Chicago, US HQ | Locations Beijing, CN HQ Hong Kong, HK | Locations Bandar Baru Bangi, MY HQ Klang, MY Shah Alam, MY Quezon City, PH Singapore, SG |
Employees | Employees 1,022 | Employees 44 | Employees 6763% increase | Employees 24,379 | Employees N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2024) | Revenue (est.) $8.3m (FY, 2020) | Revenue (est.) $65.3m (FY, 2025) | Revenue (est.) ¥31.8b (FY, 2025) | Revenue (est.) RM931.7m (FY, 2025) |
Cost of goods | Cost of goods $498.9m (FY, 2024) | Cost of goods N/A | Cost of goods $57.4m (FY, 2025) | Cost of goods ¥4.5b (FY, 2025) | Cost of goods RM513.5m (FY, 2025) |
Gross profit | Gross profit $961.4m (FY, 2024) | Gross profit N/A | Gross profit $7.9m (FY, 2025) | Gross profit ¥27.6b (FY, 2025) | Gross profit RM418.5m (FY, 2025) |
Net income | Net income $68.6m (FY, 2024) | Net income ($108.9m) (FY, 2020) | Net income ($19.1m) (FY, 2025) | Net income ¥5.3b (FY, 2025) | Net income RM87.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Kadmon
HQ
New York, US
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
View companyCosmos Holdings
HQ
Chicago, US
Employees
67
Cosmos Holdings is a fully reporting Pharmaceutical Holding Company based in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe.
View companySino Biopharmaceutical
HQ
Beijing, CN
Employees
24,379
Sino Biopharmaceutical (中国生物制药) is a company engaged in the pharmaceutical manufacturing industry.
View companyDuopharma Biotech
HQ
Bandar Baru Bangi, MY
Duopharma Biotech is a pharmaceutical company that specializes in the manufacturing, research, development, and commercialization of generic drugs.
View company